Pancreatitis Risk and Januvia
Links shared publicly online about this topic
No pancreatitis risk seen in Byetta, Januvia drugs http://link.reuters.com/wem64m
reuters.com — “No pancreatitis risk seen in Byetta, Januvia drugs http://link.reuters.com/wem64m” View full resource at reuters.com
Most Recently Shared on June 28, 2010 at 10:06 pm By:
No pancreatitis risk seen in Byetta, Januvia drugs http://link.reuters.com/wem64m
Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
fda.gov — “Cases of acute pancreatitis reported in patients treated with sitagliptin.” View full resource at fda.gov
Most Recently Shared on September 25, 2009 at 4:03 pm By:
Januvia Linked to Pancreatitis by FDA - Health Blog - WSJ
blogs.wsj.com — “An FDA notice on Merck's Januvia comes just over a year after Byetta was also linked to pancreatitis.” View full resource at blogs.wsj.com
Most Recently Shared on September 28, 2009 at 8:27 pm By:
Diabetes Drug and Pancreatitis: http://bit.ly/3RxqWo #diabetes
FDA links Januvia to pancreatitis - FiercePharma
fiercepharma.com — “Concerned by post-marketing cases of pancreatitis, FDA is adding the reports to labeling on Merck's (MRK) diabetes drug Januvia (sitagliptin) and a combo form of the drug, Janumet. The agency is... Read more...” View full resource at fiercepharma.com
Most Recently Shared on September 30, 2009 at 6:48 pm By:
RT @safety_alertss: #Drug #PtSafety #FDA links Januvia to pancreatitis Merck's #diabetes medication, new use #labeling. http://ow.ly/rLrk
No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt
reuters.com — “No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt” View full resource at reuters.com
Most Recently Shared on June 28, 2010 at 11:25 pm By:
No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 4:42 am By:
FDA Alert - FDA Revises Januvia/Janumet Prescribing Information to Include Reported Cases of Acute Pancreatitis - http://bit.ly/QlRRO
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 7:03 pm By:
FDA notified healthcare professionals of revisions to include information on reported cases of acute pancreatitis....http://short.to/rthu
FDA sees pancreatitis link with Merck's Januvia - TuDiabetes
tudiabetes.com — “WASHINGTON, Sept 25 (Reuters) - U.S. health officials said on Friday they suspect Merck & Co Inc's (MRK.N) blockbuster diabetes drug Januvia may be linked to serious cases of inflamed pancreas, but company officials disputed the connection. The Food and Drug Administration said that 88 cases of acute pancreatitis had been reported since the drug's approval in 2006 through February 2009. More details: http://www.reuters.com/article/governmentFilingsNews/idUSN2550919420090925” View full resource at tudiabetes.com
Most Recently Shared on September 29, 2009 at 7:22 pm By:
FDA sees pancreatitis link with Merck's Januvia http://bit.ly/wkq86 #diabetes
FDA sees pancreatitis link with Merck's Januvia - TuDiabetes
tudiabetes.com — “WASHINGTON, Sept 25 (Reuters) - U.S. health officials said on Friday they suspect Merck & Co Inc's (MRK.N) blockbuster diabetes drug Januvia may be linked to serious cases of inflamed pancreas, but company officials disputed the connection. The Food and Drug Administration said that 88 cases of acute pancreatitis had been reported since the drug's approval in 2006 through February 2009. More details: http://www.reuters.com/article/governmentFilingsNews/idUSN2550919420090925” View full resource at tudiabetes.com
Most Recently Shared on September 30, 2009 at 12:38 am By:
Diabetes news: FDA sees pancreatitis link with Merck's Januvia: WASHINGTON, Sept 25 (Reuters) -.. http://bit.ly/2fGiiO
FDA warns docs about Januvia and Janumet link to acute pancreatitis - Pharma Marketing Network Forums
forums.pharma-mkting.com — “Fda warns docs about januvia and janumet link to acute pancreatitis regulatory affairs” View full resource at forums.pharma-mkting.com
Most Recently Shared on September 25, 2009 at 4:45 pm By:
FDA warns docs about Januvia and Janumet link to acute pancreatitis. http://bit.ly/13e71m
Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer
newswise.com — “A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users. Sitagliptin, sold in pill form as Januvia, caused abnormalities in the pancreas of some test rats.” View full resource at newswise.com
Most Recently Shared on April 30, 2009 at 9:10 pm By:
Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer http://bit.ly/xBf4b
Medical Journal Withdraws Article About Januvia And Byetta After It Gets Letters From Two Drug Companies - Drug Injury Watch
drug-injury.com — “April 2011 Edition Of BMJ Breaks News And Provides Insight From One Who Saw An Increased Risk Of Pancreatitis (Posted by Tom Lamb at DrugInjuryWatch.com) According to a news item published April 11, 2011 by The British Medical Journal (BMJ), letters written by Merck and Novo Nordisk to Anil Rustgi, the editor-in-chief of Gastroenterology, resulted in that journal withdrawing an article which it had posted on its website about how Januvia (sitagliptin) and Byetta (exenatide) have been associated ” View full resource at drug-injury.com
Most Recently Shared on May 3, 2011 at 3:20 pm By:
RT @soulflsepulcher @TomLamb Med Journal W/draws Article About Januvia & Byetta After It Gets Letters From 2 Drug Cos http://bit.ly/lt15Cr
New Recall Alert: : Sitagliptin - Januvia and Janumet - Type Two Diabetes Drugs and Acute Pancreatitis http://bit.ly/1vkszz
usrecallnews.com — “New Recall Alert: : Sitagliptin - Januvia and Janumet - Type Two Diabetes Drugs and Acute Pancreatitis http://bit.ly/1vkszz” View full resource at usrecallnews.com
Most Recently Shared on September 25, 2009 at 6:53 pm By:
New Recall Alert: : Sitagliptin - Januvia and Janumet - Type Two Diabetes Drugs and Acute Pancreatitis http://bit.ly/1vkszz
Safety profiles of JANUVIA and JANUMET drugs established through clinical development program
news-medical.net — “Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.” View full resource at news-medical.net
Most Recently Shared on September 28, 2009 at 7:19 pm By:
Stroke News: Safety profiles of JANUVIA and JANUMET drugs established through clinical development .. http://twurl.nl/yscc41
Symposier - Diabetes drugs 2010: Victoza, Januvia, Galvus etc., by Jothydev
symposier.com — “Uploaded and shared in Youtube by: jothydev --" The Incretin based therapies got well established in type 2 diabetes in year 2010. Dr.Jothydev Kesavadev in the monthly "JDC Diabetes Gems" video describes how Liraglutide and DPP4 inhibitors normalizes blood glucose with minimal risk of hypoglycemia.” View full resource at symposier.com
Most Recently Shared on December 21, 2010 at 12:32 am By:
Diabetes drugs 2010: Victoza, Januvia, galvus etc., by Dr.Jothydev Kesavadev http://bit.ly/hhxoX3
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Reuters Health
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
The Medpedia Project
Medpedia is a long-term project to advance collaborative, transparent health and medical knowledge.
Advertisement

